Kevin Shi


0
BiosimilarOnslaught_Header

The Biosimilar Onslaught

January 05, 2016 / by Kevin Shi and Nawid Sayed / 0 Comment

Pharmaceutical companies face huge revenue uncertainties after the loss of patent exclusivity; but not all is lost.